Apart from tumor cell-derived and tumor microenvironment-derived biomarkers, in advanced HCC stages, specific laboratory parameters, like alpha-fetoprotein (AFP), and its changes during treatment, and inflammatory parameters, like C-reactive protein, have shown strong correlations with patient prognosis [10–12]. Here, AFP is linked to neoplasm.